Chemomab Therapeutics (CMMB) Cash from Financing Activities (2017 - 2023)
Chemomab Therapeutics (CMMB) posted Cash from Financing Activities of $7.16 million for FY2025, down 27.5% from $9.87 million in FY2024.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Cash from Financing Activities (2017 - 2023) Analysis & Trends
Since FY2016, Chemomab Therapeutics has reported Cash from Financing Activities for 10 years.
- Annual Cash from Financing Activities shows a five-year compound annual growth rate of 8.5% (FY2020 to FY2025).
- Annual Cash from Financing Activities has run from a low of -$808,000 in FY2022 to a high of $61.07 million in FY2021 over five years.
- Business Quant data shows CMMB's Cash from Financing Activities at $9.87 million in FY2024 (+181.6%), $3.5 million in FY2023, -$808,000 in FY2022 and $61.07 million in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Chemomab Therapeutics | 8.56 Mn | 8.56 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 2.13 Mn |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 1.37 Mn |
| Dec 31, 2022 | -869,000.00 |
| Sep 30, 2022 | 39,000.00 |
| Jun 30, 2022 | 22,000.00 |
| Dec 31, 2021 | -81,000.00 |
| Sep 30, 2021 | -72,000.00 |
| Jun 30, 2021 | 13.43 Mn |
| Mar 31, 2021 | 47.80 Mn |
| Dec 31, 2020 | 563,000.00 |
| Sep 30, 2020 | 562,000.00 |
| Jun 30, 2020 | 3.13 Mn |
| Mar 31, 2020 | 500,000.00 |
| Jun 30, 2019 | -1.20 Mn |
| Mar 31, 2019 | 27.82 Mn |
| Dec 31, 2018 | -543,000.00 |
| Sep 30, 2018 | -1.74 Mn |
| Jun 30, 2018 | 20.90 Mn |
| Mar 31, 2018 | 2.00 Mn |
API Access
Chemomab Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();